Crossmark Global Holdings’s Centessa Pharmaceuticals CNTA Stock Holding History

Crossmark Global Holdings’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,436	Closed	-$772K	–	1275
2026 Q1	$772K	Buy	+19,436	New	+$497K	0.01%	692

Crossmark Global Holdings's CNTA Position: Q2 2026 in Review

Crossmark Global Holdings sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 19,436 shares — an estimated $772K sold.

Crossmark Global Holdings first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $772K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Crossmark Global Holdings reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Crossmark Global Holdings sold 19,436 Centessa Pharmaceuticals shares in Q2 2026, an estimated $772K.
Crossmark Global Holdings first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Crossmark Global Holdings's Centessa Pharmaceuticals position peaked at $772K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.